Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ETV4
|
ENSG00000175832.13 | ETS variant transcription factor 4 |
ETS2
|
ENSG00000157557.13 | ETS proto-oncogene 2, transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ETS2 | hg38_v1_chr21_+_38805895_38805951 | 0.54 | 1.4e-03 | Click! |
ETV4 | hg38_v1_chr17_-_43545707_43545732 | -0.06 | 7.2e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.5 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
1.1 | 1.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.9 | 2.7 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.7 | 2.2 | GO:1903006 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
0.7 | 2.2 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.7 | 3.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.7 | 2.1 | GO:0070079 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
0.7 | 9.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 1.2 | GO:0090264 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
0.6 | 3.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.5 | 1.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.5 | 2.5 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.5 | 5.2 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.5 | 0.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.5 | 2.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 | 5.0 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.4 | 1.7 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.4 | 1.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.4 | 1.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.4 | 1.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.4 | 1.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.4 | 1.8 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.4 | 5.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.3 | 1.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.3 | 1.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.3 | 1.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.3 | 2.0 | GO:0033590 | response to cobalamin(GO:0033590) |
0.3 | 1.0 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.3 | 6.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 2.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.3 | GO:0044691 | tooth eruption(GO:0044691) |
0.3 | 1.3 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.3 | 1.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 3.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.9 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.3 | 0.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 2.1 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.9 | GO:0035922 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
0.3 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.8 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.3 | 1.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.6 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
0.3 | 1.1 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.3 | 1.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.0 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.3 | 0.8 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.3 | 0.8 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 1.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 1.0 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.2 | 1.9 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 4.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.2 | 0.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 6.6 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.2 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.9 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 1.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.2 | 5.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.2 | 1.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.8 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.2 | 1.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.6 | GO:1900082 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 2.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.6 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 3.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.6 | GO:0021503 | neural fold bending(GO:0021503) |
0.2 | 0.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.2 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.5 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.2 | 2.1 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.2 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 1.2 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.5 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
0.2 | 1.1 | GO:0071503 | positive regulation of lipoprotein particle clearance(GO:0010986) response to heparin(GO:0071503) |
0.2 | 0.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.2 | 0.5 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.2 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.5 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.2 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.2 | 1.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.6 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.6 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 0.8 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 5.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.1 | 0.4 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.1 | 0.4 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 2.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.6 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 1.8 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.7 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 1.4 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 1.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 2.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 4.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 16.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) macropinocytosis(GO:0044351) |
0.1 | 1.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 2.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0002554 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.1 | 0.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.6 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 1.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.9 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 1.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 1.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 1.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 1.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 3.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:0072560 | type B pancreatic cell maturation(GO:0072560) |
0.1 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.4 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
0.1 | 0.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.6 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.8 | GO:0060717 | chorion development(GO:0060717) |
0.1 | 0.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 0.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 1.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 1.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.2 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.1 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 1.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
0.1 | 5.0 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 0.2 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.1 | 0.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 2.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.1 | 0.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 6.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.6 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 3.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.7 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.5 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 3.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 1.4 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.0 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) |
0.0 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.2 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
0.0 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.9 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 1.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.9 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.0 | 0.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 1.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.0 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
0.0 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 4.0 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.1 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.0 | 1.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 5.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 3.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:0060744 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
0.0 | 0.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 4.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 1.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.3 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 2.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 1.0 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.0 | 0.1 | GO:0035936 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.0 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.7 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0009631 | cold acclimation(GO:0009631) |
0.0 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.0 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.0 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.0 | 1.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0045590 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.9 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 1.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 0.3 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
0.0 | 1.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.9 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 1.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 1.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.6 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 1.4 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:0090234 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.4 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 1.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 3.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.0 | 0.1 | GO:1901908 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.0 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:1902992 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.0 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.6 | 6.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 1.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.5 | 9.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 1.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.4 | 4.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 0.7 | GO:1990617 | CHOP-ATF4 complex(GO:1990617) |
0.4 | 2.8 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 3.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 6.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 1.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 1.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.3 | 0.9 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 5.3 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 3.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.7 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.2 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 1.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.2 | 1.2 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 2.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.6 | GO:0001534 | radial spoke(GO:0001534) |
0.2 | 5.9 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 2.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.7 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 3.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 7.3 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 2.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.7 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 1.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 3.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.8 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 11.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 2.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 7.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 4.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
0.1 | 10.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 2.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 4.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.0 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 1.4 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.4 | GO:0031673 | H zone(GO:0031673) |
0.0 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 1.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.1 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.0 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 1.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 3.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 2.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 3.3 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0070449 | elongin complex(GO:0070449) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 1.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 3.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0032116 | SMC loading complex(GO:0032116) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 12.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 1.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0035375 | zymogen binding(GO:0035375) |
1.1 | 3.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
1.0 | 3.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.7 | 2.1 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
0.7 | 5.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.6 | 6.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 3.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.5 | 2.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.5 | 4.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 3.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 1.3 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.4 | 1.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.4 | 1.7 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.4 | 5.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.1 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.4 | 1.1 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.4 | 1.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 3.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.0 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.3 | 1.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.4 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.3 | 1.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.6 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.3 | 1.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.3 | 1.3 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.3 | 0.8 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
0.2 | 3.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 2.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 1.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.2 | 1.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 0.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 1.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 5.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.6 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 1.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 7.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.7 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 2.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.2 | 0.5 | GO:0047693 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.2 | 5.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 4.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.6 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.7 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.1 | 1.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 2.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 2.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.1 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 1.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 1.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 2.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.2 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.1 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.2 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
0.1 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 8.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.2 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.1 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.9 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.1 | 0.1 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
0.1 | 0.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 8.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 14.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 2.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 1.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 5.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 3.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 5.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.3 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 2.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 1.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.0 | 2.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 13.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 9.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 5.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 5.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 5.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 20.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 4.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 5.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 5.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 3.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.6 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 2.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 2.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 3.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 5.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 8.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 13.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 5.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 7.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 5.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 4.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 4.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 9.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 5.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 3.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 4.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 1.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 3.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 4.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 1.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |